The "Global Drug Screening Market by Product & Services, by Sample Type, by End User - Global Opportunity Analysis and Industry Forecast, 2017-2023" report has been added to Research and Markets' offering.
Drug screening is a type of test carried out to determine an individual's scope and degree of drug abuse. The global drug screening market is expected to reach $9,447 million in 2023 from $5,214 million in 2016 registering a CAGR of 8.7% from 2017 to 2023
Drug testing is mandated imperative by many organizations and institutes to maintain an addiction free and sober workforce. Healthy and sober workforce helps maintain high productivity and a proper work environment. Special rules are issued by government regarding use of drug abuse in public places such as railway stations, airports etc. to ensure safety of local population. Use of performance enhancement drugs often termed as doping' is increasing problem in professional sports which is regulated by international sports organizations by establishing rules and prohibiting drugs.
Technological advancements in drug screening devices and upsurge in applications of these devices in market drives the drugs screening market. Moreover, increase in alcohol consumption and illicit use of prescribed drugs by ageing population, increase in government funding for drug testing programs augment market growth. However, the fact that drug testing is considered as a violation right in some countries, precision and accuracy issues regarding breath analyzers, ban on alcohol consumption in various countries restrain the market growth. The use of advanced technology in the drug testing devices and untapped emerging economies offer lucrative opportunities for the market players.
KEY PLAYERS PROFILED
- Alere, Inc.
- Drgerwerk AG & Co. KGAA
- Abbott Laboratories
- Hoffmann-La Roche AG
- Biorad Laboratories, Inc.
- Siemens AG
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- Quest Diagnostics Incorporated
- Express Diagnostics International Inc.
Other players in the value chain include
- BioMerieux
- Shimadzu
- CannAmm Occupational Testing Services
- Agilent Technologies
- DiaSorin
- Eiken
- Merck
- Fujirebio
- Synergy Health PL.
Key Topics Covered:
Chapter 1 Introduction
Chapter 2 Executive Summary
Chapter 3 Market Overview
Chapter 4 Drug Screening Market, By Product & Service
Chapter 5 Drug Screening Market, By Sample Type
Chapter 6 Drug Screening Market, By End User
Chapter 7 Drug Screening Market, By Geography
Chapter 8 Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/t6fgwv/global_drug
View source version on businesswire.com: http://www.businesswire.com/news/home/20171017005868/en/
Contacts:
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Drug
Abuse Screening
